Summary
Disclaimer: Due to the nature of the report page numbers are unavailable and Published Weekly or Monthly since 2005 depending on the type of subscription."Upon completion of the purchase process, the publisher La Merie will contact the customer by e* mail to confirm the subscription and validate the e* mail address for delivery of the products. In case of multi* user licenses, the publisher will ask for all the individual e* mail addresses to allow desktop delivery of the product on each Monday. The product will be delivered in pdf format on a weekly basis (50* times a year or four* to five* times during a one* month subscription). After termination of the subscription period, the subscription automatically expires. A new subscription would have to be purchased to continue the subscription".
Product description
R&D Pipeline News is your weekly tool for analysis of biopharmaceutical R&D. It is available by monthly or annual subscription. The annual subscription consists of 50 issues, the monthly of four or five issues.
R&D Pipeline News Therapeutic Area Edition will keep you up* to* date with the latest R&D projects of the biopharmaceutical industry, with all the relevant treatment modalities and with competitive information about ongoing R&D projects for a given Target, Technology or Company.
R&D Pipeline News Therapeutic Area Edition will keep you up* to* date with the latest R&D projects of the biopharmaceutical industry, with all the relevant treatment modalities and with competitive information about ongoing R&D projects for a given Target, Technology or Company. See our past Target and Company Pipelines in R&D Pipeline News
The R&D information is presented in an easy* and rapid* to* screen tabular format and sorted by Product Categories.
The Therapeutic Area Edition lists the News in groups according to the product category, e.g. antibodies or vaccines etc. The product is delivered every week via e* mail as a PDF document directly to your desktop.
One* month and one* year subscriptions are available as single user license, departmental license, site license and global license. After completion of the purchase process, we will get in touch with you to gather the e* mail addresses of your institution for individual desktop delivery.
For further information please contact us at sales@lamerie.com
What is R&D Pipeline News?
R&D Pipeline News is a premier information source about research and development (R&D) projects in the pipeline of the biopharmaceutical industry and is directed to all stakeholders in R&D. R&D Pipeline News covers all relevant treatment modalities, incl. drugs, medical devices, biomaterials, combination products, cell therapy and drug delivery products. The news are retrieved from business as well as scientific communications over all stages of the R&D process * from research to approval.
Key Product Features
- Weekly tool for R&D analysis;
- Individual e* mail delivery for multi* users;
- 8000+ unique compounds covered;
- Independent and expert editorial staff;
- Coverage of all treatment modalities;
- Featured company pipelines;
- Featured target and indication pipelines;
- Systematic presentation format for easy and rapid screening of news.
Target Audience
- R&D Professionals;
- Consultants;
- Competitive & Business Intelligence Professionals;
- Scientific & Business Information Services;
- Drug Delivery Technologists;
- Project Leaders and Therapeutic Area Heads;
- Business Development & Licensing;
- Strategic Planning & Analysis;
- Investment and Fonds Managers;
- Technology & Regulatory Affaisrs Specialists;
- Project & Product Developers;
- R&D Directors and Managers;
|
